Ludwig, Marius
Basti, Alireza
Yalçin, Müge
Schulte, Johannes H.
Relógio, Angela https://orcid.org/0000-0002-9165-2439
Funding for this research was provided by:
Dr. Rolf M. Schwiete Stiftung
Berlin Institute of Health
Berlin School of Integrative Oncology BSIO
Charité - Universitätsmedizin Berlin
Article History
Received: 9 May 2022
Accepted: 17 February 2023
First Online: 4 March 2023
Declarations
:
: This protocol was approved by the Ethics Committee (Study ID: EA2/230/21) of the Charité Universitätmedizin Berlin. For the prospective sub-study, if participants who meet the eligibility criteria wish to take part in the study after they have been informed about its procedures, they will be asked to sign an informed consent form. For all participants under 18 years old, informed consent to participated in the study will be provided (was provided, for the already recruited participants) by a parent and/or a legal guardian.
: Not applicable: No data from any study participant were included in this manuscript.
: A.R. has filled patents (PCT/EP2021/073798 and PCT/EP2021/073802) related to biomarkers for characterizing the circadian clock. All other authors declare that they have no competing interests.